Patient preference for second and third line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study

Patient preference is key for medication selection in chronic medical conditions, like type 2 diabetes, where there are many different drugs available. Patient preference balances potential efficacy with potential side effects. As both aspects of drug response can vary markedly between individuals t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nat Med
Egile Nagusiak: Shields, Beverley M, Angwin, Catherine D, Shepherd, Maggie H, Britten, Nicky, Jones, Angus G, Sattar, Naveed, Holman, Rury, Pearson, Ewan R, Hattersley, Andrew T
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2023
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7614215/
https://ncbi.nlm.nih.gov/pubmed/36477734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-022-02121-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak